34. 神経線維腫症 Neurofibromatosis Clinical trials / Disease details

臨床試験数 : 133 / 薬物数 : 186 - (DrugBank : 67) / 標的遺伝子数 : 79 - 標的パスウェイ数 : 190

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01365468 (ClinicalTrials.gov)	April 2012	27/5/2011	Efficacy and Safety of RAD001 in Treating Plexiform Neurofibromas (PN) Associated With Neurofibromat ...	A Phase II Study of RAD001 in the Treatment of Patients With Plexiform Neurofibromas (PN) Associated ...	Plexiform Neurofibroma Associated With Neurofibromatosis Type 1	Drug: Everolimus (RAD001)	Novartis Pharmaceuticals	NULL	Terminated	6 Years	N/A	All	9	Phase 2	Israel
2	NCT01419639 (ClinicalTrials.gov)	October 2011	17/8/2011	Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2	Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2	Neurofibromatosis Type II	Drug: Everolimus (RAD001) , Afinitor®	New York University School of Medicine	Novartis Pharmaceuticals;The Children's Tumor Foundation	Completed	3 Years	N/A	All	10	Phase 2	United States

First Previous1Next Last